e.l.f. Cosmetics
ELF
$97.79
+1.40%
e.l.f. Beauty, Inc. is a multi-brand beauty company that develops and sells cosmetics and skincare products — including eyeliner, mascara, foundation, lipstick, moisturizers, and cleansers — under its flagship e.l.f. Cosmetics brand as well as acquired labels such as Rhode, primarily through mass retail, e-commerce, and international channels. The company has positioned itself as a value-priced disruptor in the beauty industry, undercutting legacy cosmetics giants on price while leaning into inclusive, vegan, and cruelty-free product positioning that resonates with younger consumers. The current investor narrative is dominated by the Rhode acquisition, which management credits with driving a strong fiscal Q1 beat and raised guidance, alongside a new hair care line and tariff refunds that helped fuel a sharp June rally. At the same time, debate persists around whether the company's aggressive expansion and acquisition-driven growth can be sustained profitably, given a recent swing to a quarterly net loss and a steep year-over-year share price decline that has left the stock well below its 52-week high.…
ELF
e.l.f. Cosmetics
$97.79
Related headlines
Investment Opinion: Should I buy ELF Today?
Rating: Hold. The core thesis is that ELF offers strong revenue growth and a discounted valuation, but the recent swing to a net loss and integration risks warrant caution until profitability recovers. The analyst consensus is 'buy' with an average target of $102.13, implying 5.9% upside, but the wide target range ($65–$127) reflects low conviction.
Supporting evidence: Revenue grew 35.07% year-over-year to $449.29 million, gross margin remains healthy at 72.66%, and the forward PE of 25.08x is reasonable for this growth rate. The company generated $190.06 million in trailing free cash flow, and the current ratio of 2.35 indicates solid liquidity. However, the net loss of $49.37 million and negative EBITDA of -$17.56 million are red flags. The PS ratio of 2.16x is near multi-year lows, suggesting the market has already priced in significant pessimism.
Risks and conditions: The biggest risks are a continued profitability downturn, integration challenges with Rhode, and high beta exposure to market rotations. This Hold would upgrade to Buy if the company returns to positive net income and operating margin exceeds 10% for two consecutive quarters, or if the forward PE compresses below 20x. It would downgrade to Sell if revenue growth decelerates below 20% or if gross margin falls below 65%. Relative to its history, the stock appears undervalued, but relative to peers, it is fairly valued given the earnings uncertainty.
Sign up to view all
ELF 12-Month Price Forecast
ELF presents a high-risk, high-reward scenario. The company's strong revenue growth and discounted valuation are offset by a recent swing to a net loss and integration risks. The analyst consensus is constructive, but the wide target range signals uncertainty. I would upgrade to bullish if the company demonstrates two consecutive quarters of positive net income and operating margin above 10%. I would downgrade to bearish if revenue growth falls below 20% or if gross margin drops below 65%. The current risk/reward is balanced, favoring a neutral stance until profitability is proven.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on e.l.f. Cosmetics's 12-month outlook, with a consensus price target around $102.13 and implied upside of +4.4% versus the current price.
Average Target
$102.13
0 analysts
Implied Upside
+4.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $127
Analyst target range
Coverage is solid, with 16 analysts following ELF and a consensus recommendation of "buy" (recommendation mean of 1.72, where 1.0 is a strong buy). The average price target is $102.13, implying roughly 5.9% upside from the current price of $96.44 — a modest but positive signal. Sentiment leans bullish but not overwhelmingly so: recent institutional ratings from May 2026 show a mix of Buy/Overweight calls from B. Riley, BofA, Jefferies, JP Morgan, and Canaccord, balanced against Neutral/Equal Weight stances from Piper Sandler, Morgan Stanley, and UBS, indicating the analyst community is constructive on the growth story but cautious on execution and valuation.
The target range is wide, from a low of $65.00 to a high of $127.00 — a spread of roughly 95% of the current price, which signals high uncertainty and low conviction on the precise trajectory. The high target of $127 implies multiple expansion and successful Rhode integration driving accelerating revenue and margin recovery, while the low target of $65 prices in margin compression, integration missteps, or a consumer slowdown that keeps earnings depressed. Notably, the most recent ratings actions (May 2026) were largely reiterations rather than upgrades or downgrades, suggesting analysts are in a wait-and-see mode pending clearer evidence that the profitability downturn is temporary. The estimated average EPS of $5.49 and revenue of $2.56 billion for the coming year imply the Street expects a substantial earnings rebound from the current near-zero trailing EPS, and the stock's ability to hit those estimates will likely determine whether it gravitates toward the high or low end of the target range.
Drowning in data?
Find the real signal!
Bulls vs Bears: ELF Investment Factors
The bull case rests on robust 35% revenue growth, a reasonable 25x forward PE, strong 71% gross margins, and a consensus buy rating with 5.9% upside to the average target. The bear case highlights the recent swing to a net loss, a sharp SG&A increase, high beta and a 66% max drawdown, and a wide analyst target range that signals uncertainty. Currently, the bear evidence appears slightly stronger because the profitability downturn is recent and unresolved, while the bull case depends on a recovery that has not yet been proven. The single most important tension is whether the Rhode acquisition and new hair care line can drive sustainable profitable growth, or whether integration costs and margin pressure will persist. Resolution of this tension—likely through upcoming earnings—will determine whether the stock gravitates toward the $127 high target or the $65 low target.
Bullish
- Rhode acquisition drives 35% revenue growth: Latest quarterly revenue of $449.29 million grew 35.07% year-over-year, fueled by the Rhode acquisition and new hair care line. This top-line momentum is well above mature consumer staples peers and supports the growth narrative.
- Forward PE of 25x is reasonable for growth: The forward PE of 25.08x is far more meaningful than the distorted trailing PE of 134.69x, and it aligns with analyst EPS estimates of $5.49 for the coming year. This multiple is not stretched for a company growing revenue at 35%.
- Strong gross margins near 71%: Gross margin remains robust at 72.66% in the latest quarter and 70.72% on a trailing basis, consistent with the 69–73% range over the past two years. This indicates the core product economics are intact despite bottom-line pressure.
- Analyst consensus buy with 5.9% upside: 16 analysts cover ELF with a consensus recommendation of 'buy' (mean 1.72) and an average price target of $102.13, implying 5.9% upside from the current price of $96.44. The high target of $127 suggests significant upside if execution improves.
Bearish
- Swing to net loss and negative EBITDA: The latest quarter posted a net loss of $49.37 million (net margin -10.99%) and negative EBITDA of -$17.56 million, a stark reversal from the prior quarter's $39.38 million net income. This raises serious questions about the profitability of the Rhode integration.
- SG&A spike erodes operating leverage: SG&A jumped to $319.14 million in Q4 from $279.96 million in Q3, driving operating income down to just $7.32 million (operating margin 1.63%). The loss was driven by expense growth, not gross margin compression, highlighting integration and scaling costs.
- High beta and severe drawdown: With a beta of 1.595, ELF is roughly 60% more volatile than the market, and the stock has suffered a 66.2% maximum drawdown. The 34.25% one-year decline and 49.26% relative underperformance versus SPY underscore the fragility of the recovery.
- Wide analyst target range signals uncertainty: The target range spans from $65 to $127, a 95% spread around the current price, indicating low conviction on the trajectory. The low target of $65 prices in margin compression and integration missteps, representing 32.6% downside.
ELF Technical Analysis
ELF is in a volatile recovery phase rather than a clean trend. The stock is down 34.25% over the past year, yet it has rallied 50.22% over the past three months and 23.94% year-to-date, a sharp divergence that signals a bottoming-and-rebound pattern rather than sustained momentum. At $96.44, the stock sits at roughly 48% of its 52-week range (low of $48.82, high of $147.75), meaning it has recovered meaningfully off the lows but remains far below prior highs — a positioning that suggests room for upside if the recovery holds, but also substantial overhead supply from trapped holders. The 66.2% maximum drawdown underscores how severe the prior decline was and how fragile the current recovery remains.
Short-term momentum has cooled even as the intermediate trend stays positive. The stock is down 3.22% over the past month versus a 50.22% gain over three months and 33.02% over six months, indicating a deceleration or consolidation after a powerful spring-and-summer rally. Relative strength tells the same story: ELF outperformed SPY by 48.22 percentage points over three months and 15.58 points over six months, but underperformed by 2.26 points over the past month as SPY slipped only 0.96%. This one-month underperformance against a modestly negative market suggests profit-taking and mean reversion after the June–August surge, rather than a full trend reversal, especially with the stock still up 3.34% on the most recent session on volume of roughly 1.82 million shares.
Key technical levels are well defined. Support sits near the 52-week low of $48.82, with a more immediate psychological floor around the $90–$93 area where the stock has recently consolidated; a breakdown below that zone would put the $48.82 low back in play and signal the recovery has failed. Resistance is anchored at the 52-week high of $147.75, with the recent $109.67 peak (September 4) acting as the first hurdle — a breakout above $110 would confirm renewed momentum, while failure there risks a deeper pullback. With a beta of 1.595, ELF is roughly 60% more volatile than the broader market, meaning position sizing should be conservative and stop-losses wider than for a low-beta name; the 1.86 short ratio adds potential for sharp squeezes in either direction.
Beta
1.59
1.59x market volatility
Max Drawdown
-66.2%
Largest decline past year
52-Week Range
$49-$148
Price range past year
Annual Return
-30.1%
Cumulative gain past year
| Period | ELF Return | S&P 500 |
|---|---|---|
| 1m | -4.1% | +1.0% |
| 3m | +54.0% | +5.4% |
| 6m | +40.4% | +17.8% |
| 1y | -30.1% | +16.5% |
| ytd | +25.7% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ELF Fundamental Analysis
Revenue growth remains robust but lumpy. The most recent quarter (ended 2026-03-31) posted revenue of $449.29 million, up 35.07% year-over-year, a strong headline figure that reflects the Rhode acquisition contribution. However, the multi-quarter trend shows volatility: revenue was $353.74 million in Q1 FY2026, $343.94 million in Q2, $489.51 million in Q3, and $449.29 million in Q4, with the Q3-to-Q4 sequential decline suggesting seasonality or integration effects rather than a smooth acceleration. The single reportable segment limits visibility into which brands are driving growth, but management commentary and news flow point to Rhode and the new hair care line as the primary growth engines, while the core e.l.f. brand faces tougher comparisons.
Profitability has deteriorated sharply at the bottom line despite healthy gross margins. The latest quarter produced a net loss of $49.37 million (net margin of -10.99%) and negative EBITDA of -$17.56 million, a stark reversal from the prior quarter's $39.38 million net income and $87.73 million EBITDA. Gross margin remains strong at 72.66% in the latest quarter and 70.72% on a trailing basis, consistent with the 69–73% range seen over the past two years, indicating the core product economics are intact. The loss appears driven by a spike in operating expenses — SG&A of $319.14 million in Q4 versus $279.96 million in Q3 — and a $67.85 million swing in total other income/expenses, likely tied to acquisition-related and interest costs, rather than gross margin compression.
Balance sheet and cash flow metrics are mixed but manageable. The company generated $190.06 million in trailing free cash flow and $102.46 million in operating cash flow in the latest quarter against just $1.89 million in capital expenditure, demonstrating strong cash conversion. Liquidity is solid with a current ratio of 2.35 and a cash balance of $289.69 million, while debt-to-equity of 0.81 and a debt ratio of 0.38 reflect the leverage taken on for the Rhode acquisition. However, ROE is only 2.33% and ROA 5.14%, both depressed by the recent loss, and the cash flow-to-debt ratio of 0.11 is low, meaning the company relies on internally generated cash plus its existing cash pile rather than new external financing to fund growth — a reasonable position, but one that leaves less cushion if profitability does not recover quickly.
Quarterly Revenue
$449292000.0B
2026-03
Revenue YoY Growth
+35.1%
YoY Comparison
Gross Margin
72.7%
Latest Quarter
Free Cash Flow
$190062000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ELF Overvalued?
Because trailing net income is positive but minimal — EPS of $0.0075 and trailing net income implying a PE of 134.69x — the trailing PE is distorted and not the most informative metric; the forward PE of 25.08x is far more meaningful and is the primary metric selected here. The enormous gap between the 134.69x trailing PE and 25.08x forward PE implies the market expects a dramatic earnings recovery, consistent with analyst EPS estimates of $5.49 for the coming year versus the near-zero trailing figure. The PS ratio of 2.16x and EV/Sales of 3.46x provide cleaner top-line anchors given the earnings volatility.
Relative to the broader Household & Personal Products sector, ELF's multiples look mixed. A PS ratio of 2.16x and EV/Sales of 3.46x are not obviously stretched for a company growing revenue 35% year-over-year, and the forward PE of 25.08x is reasonable for a high-growth beauty name, though the PEG ratio of -1.74 is negative and therefore not useful given the trailing earnings distortion. The EV/EBITDA of 25.89x is elevated and reflects the depressed trailing EBITDA base; on normalized EBITDA the multiple would be considerably lower. The premium embedded in these multiples appears justified by superior growth relative to mature consumer staples peers, but the recent swing to a net loss means the market is paying for a recovery that has not yet been proven.
Historically, ELF's valuation has compressed dramatically. The PS ratio has fallen from 35.22x in Q1 FY2025 and 22.48x in Q2 FY2026 to just 2.16x today, and the PB ratio has dropped from 16.24x to 3.12x over the same span — placing the stock near the bottom of its own multi-year valuation band. This compression reflects both the sharp share price decline and the earnings deterioration, and it cuts both ways: it could represent a genuine value opportunity if the Rhode-driven growth reaccelerates profitability, or it could signal that the market is pricing in structural margin pressure and integration risk. The forward PE of 25.08x versus a historical range that has spanned from roughly 27x to over 200x suggests the stock is now valued more like a mature consumer company than the high-multiple growth story it once was.
PE
134.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 27x~101x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The company swung to a net loss of $49.37 million in the latest quarter, with negative EBITDA of -$17.56 million, and operating margin collapsed to 1.63% from 13.80% in the prior quarter. SG&A surged to $319.14 million, up 14% sequentially, driven by acquisition-related costs and scaling expenses. Debt-to-equity of 0.81 and a cash flow-to-debt ratio of 0.11 indicate limited financial flexibility if profitability does not recover soon. Additionally, revenue is concentrated in the core e.l.f. brand and the recently acquired Rhode, with limited visibility into segment performance.
Market and competitive risks are elevated. The stock trades at a forward PE of 25.08x, which is reasonable for 35% growth but leaves little room for error; any deceleration could compress the multiple. With a beta of 1.595, ELF is highly sensitive to market rotations, as evidenced by its 49.26% underperformance versus SPY over the past year. The beauty sector is intensely competitive, and legacy players could respond with price cuts or new products, threatening ELF's value positioning. Recent news highlights tariff refunds and a new hair care line, but also notes a volatile macro backdrop with sticky inflation and geopolitical risks that could pressure consumer discretionary spending.
Worst-case scenario: A continued profitability downturn, perhaps due to Rhode integration missteps or a consumer slowdown, could drive the stock back to its 52-week low of $48.82, representing a 49.4% decline from the current price of $96.44. The analyst low target of $65 implies a 32.6% downside, but the 52-week low is a more extreme reference. If the company fails to hit the estimated EPS of $5.49 and revenue of $2.56 billion, the stock could test the low end of its historical valuation band, with PS falling below 1.5x. Investors could lose nearly half their capital in this adverse scenario.
FAQ
The key risks include: 1) Financial risk: The company swung to a net loss of $49.37 million and has a debt-to-equity of 0.81, with a low cash flow-to-debt ratio of 0.11. 2) Integration risk: The Rhode acquisition may not deliver expected synergies, and SG&A has surged to $319.14 million. 3) Market risk: High beta of 1.595 makes the stock vulnerable to market rotations, as shown by a 49.26% underperformance versus SPY over the past year. 4) Competitive risk: Intense competition in beauty could pressure margins, especially if legacy players cut prices. These risks are ranked from highest to lowest severity.
Our 12-month forecast has three scenarios: Bull case (25% probability) targets $115-$127, assuming successful Rhode integration and a return to profitability. Base case (50% probability) targets $95-$110, assuming gradual margin recovery and revenue growth of 20-25%. Bear case (25% probability) targets $65-$75, assuming continued losses and decelerating growth. The base case is most likely, hinging on the company achieving the estimated EPS of $5.49. The wide range reflects high uncertainty, and the stock could be volatile around earnings.
ELF appears undervalued relative to its own history but fairly valued relative to peers. The PS ratio of 2.16x is near multi-year lows, down from 35.22x in Q1 FY2025, and the forward PE of 25.08x is reasonable for a company growing revenue at 35%. However, the trailing PE of 134.69x is distorted by near-zero earnings, and the EV/EBITDA of 25.89x is elevated. The market is pricing in a significant earnings recovery, as evidenced by the gap between trailing and forward PE. If the company meets the estimated EPS of $5.49, the stock could re-rate higher; if not, it could fall toward the low target of $65.
From a risk/reward perspective, ELF is a speculative buy for investors who can tolerate volatility. The stock trades at $96.44, with a consensus analyst target of $102.13 (5.9% upside) and a high target of $127 (31.7% upside). However, the recent net loss of $49.37 million and negative EBITDA of -$17.56 million are concerning. The biggest downside risk is a return to the 52-week low of $48.82, representing a 49.4% loss. For long-term investors with a high risk tolerance, the discounted valuation (PS of 2.16x) and strong revenue growth (35% YoY) could offer attractive returns if profitability recovers. For risk-averse investors, it is best to wait for clearer signs of sustainable profitability.
ELF is more suitable for long-term investment (at least 2-3 years) given its growth stage and volatility. The stock has a beta of 1.595, no dividend, and earnings visibility is low due to integration and margin uncertainty. Short-term trading is risky because of the high volatility and event-driven moves around earnings. A long-term horizon allows time for the Rhode acquisition to integrate and for profitability to recover. Investors should be prepared for drawdowns, as the stock has experienced a 66.2% max drawdown. A minimum holding period of 2-3 years is suggested to ride out volatility and realize the growth potential.
